ATRI Atrion Corp. Cumulative Company Assets

Official company branding of Atrion Corp. (ATRI)

The linear price action on the total assets chart for Atrion Corporation (ATRI) reaches the value of 263.87, confirming a systematic expansion of production capacities for infusion and cardiology products. The business of Atrion Corporation is based on the creation of high-precision components for ophthalmological and cardiac equipment. The stability of its position is ensured by patent protection of innovations and long-term agreements with major OEM partners.

Company Total Assets: Atrion Corp. (ATRI) for 07/04/2022 - 08/31/2024

Financial and market metric breakdowns for Atrion Corp (ATRI)

- current quotes and average value forecast:
Market Chart atrioncorp.com|ATRI - Price Target Chart
- market capitalization data:
Market Valuation Atrion Corporation Inc.|ATRI - Enterprise Value
- company book value details:
Net Asset Value per Share Atrion|ATRI - Book Capitalization|Capitalization to Book Value Ratio atrioncorp.com|ATRI - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Atrion Corporation|ATRI - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Atrion Corporation Inc.|ATRI - Company Aggregate Debts|Debts to Book Capitalization Atrion Corporation Inc.|ATRI - Company Long-Term Debt|Company Short-Term Debt Atrion|Intermediate Coverage Ratio atrioncorp.com
- company profitability and valuation multiples indicators:
ATRI - Net Profit
Fundamental valuation:Atrion Corporation
Mass-produced product of Atrion Corporation

The sensitivity of this metric to operational efficiency allows for an assessment of total resources and liabilities through a reverse ROA calculation, revealing the real dynamics of capitalization. Stable demand for specialized medical components ensures high asset margins for Atrion Corporation (ATRI), making changes in the company's financial assets a reliable indicator of business scaling under strict debt load control.

Main competitors

ISRG - Company Total Asset Base|Aggregate Company Assets Danaher|Cumulative Company Assets BD (BDX)|Company Total Assets STE|WST - Company Assets|Company Total Assets BAX (Baxter International)|MASI: Total Business Assets|Stevanato Group - Company Total Assets|Company Total Asset Base Teleflex Inc. TFX|MMSI: Company Total Assets|Cumulative Company Assets Nobel Biocare|ICUI (ICU Medical, Inc.) - Company Total Assets|Company Total Assets dentsplysirona.com|Aggregate Company Assets LeMaitre Vascular (LMAT)|Aggregate Company Assets ATRC (AtriCure Inc)|STAAR Surgical Corp - Cumulative Company Assets|Aggregate Asset Value NAGE|ZimVie Inc. - Company Total Assets|Company Total Asset Base angiodynamics.com ANGO|Cerus (CERS) - Aggregate Company Assets|Total Business Assets TKNO|Aggregate Company Assets Monogram Technologies Inc|Sharps Tech (STSS) - Company Total Asset Base|Cumulative Company Assets INFU (InfuSystem Holdings)|Aggregate Business Assets UTMD|Aggregate Company Assets KORU Medical KRMD|Aggregate Asset Value NYXH|MBOT: Cumulative Company Assets|PDEX - Company Total Assets|Zentek Ltd. (ZTEK) - Aggregate Company Assets|Cumulative Company Assets elutia.com|MLSS (Milestone Scientific Inc.) - Company Total Assets|Company Assets NEXGEL Inc. NXGL|Aggregate Company Assets Retractable Technologies (RVP)|harvardbioscience.com - Total Business Assets|Femasys Inc. - Cumulative Company Assets|Aggregate Business Assets MHUA (Meihua Medical Technologies)|POAI - Aggregate Company Assets|Company Total Asset Base Callan JMB Inc CJMB|NURO: Company Total Assets